Sana Biotechnology, Inc.

About Sana Biotechnology, Inc.

Sana Biotechnology aims to lead in creating novel medicines by repairing and controlling genes in cells or replacing missing or damaged cells to solve the underlying causes of many diseases, with a focus on meaningfully improving patient outcomes.

Products & Services

Engineered Cell Therapies:Innovative drug candidates using engineered cells as medicines to deliver unprecedented benefits to patients, targeting diseases like cancer, diabetes, and autoimmune disorders.

Specialties

Engineered Cell Therapies Cellular Biology Gene Repair and Control Therapeutics Development Machine Learning in Biotech

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 86300000 MR: - FA: approximately $86.3 million FAN: 86300000	D: 2025-08-20 FD: 2025-08-20	4 investors
2	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: $75.0 million FAN: 75000000	D: 2025-08-06 FD: 2025-08-06	4 investors
3	RT: Public Offering T: - FT: Public Offering	A: 189750000 MR: - FA: approximately $189.75 million FAN: 189750000	D: 2024-02-12 FD: 2024-02-12	4 investors
4	RT: Public Offering T: - FT: Public Offering	A: 165000000 MR: - FA: $165.0 million FAN: 165000000	D: 2024-02-08 FD: 2024-02-08	4 investors
5	RT: Public Offering T: - FT: Public Offering	A: 125000000 MR: - FA: $125.0 million FAN: 125000000	D: 2024-02-07 FD: 2024-02-07	4 investors

Underwritten Public Offering Latest

2025-08-20

$86.3M

4 investors (Pro only)

Public Offering 2025-08-06

$75.0M

Public Offering 2024-02-12

$189.8M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steve Harr

President and Chief Executive Officer, M.D.

B

Bernard J. "Barney" Cassidy

Executive Vice President and General Counsel

J

John Gerecitano

Senior Vice President of Oncology Research and Development

G

Gary Meininger, MD

Chief Medical Officer

D

Dhavalkumar Patel

Executive Vice President and Chief Scientific Officer

S

Snehal Patel

Executive Vice President and Chief Technical Officer

View 16 more team members with Pro

Unlock Full Team Directory

Recent News